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Abstract 
Porous melt-derived bioactive glass scaffolds with interconnected pore networks suitable for 
bone regeneration were produced without the glass crystallising. ICIE 16 (49.46% SiO2, 
36.27% CaO, 6.6% Na2O, 1.07% P2O5 and 6.6% K2O, in mol%) was used as it is a 
composition designed not to crystallise during sintering. Glass powder was made into porous 
scaffolds by using the gel-cast foaming technique. All variables in the process were 
investigated systematically to devise an optimal process. Interconnect size was quantified 
using mercury porosimetry and X-ray microtomography (CT). The reagents, their relative 
quantities and thermal processing protocols were all critical to obtain a successful scaffold. 
Particularly important were particle size (a modal size of 8 m was optimal); water and 
catalyst content; initiator vitality and content; as well as the thermal processing protocol. 
Once an optimal process was chosen, the scaffolds were tested in simulated body fluid (SBF) 
solution. Amorphous calcium phosphate formed in 8 h and crystallised hydroxycarbonate 
apatite (HCA) formed in 3 days. The compressive strength was measured to be approximately 
2 MPa for a mean interconnect size of 140 m between the pores with a mean diameter of 
379 m, which is thought to be suitable porous network for vascularised bone regeneration. 
This material has the potential to bond to bone more rapidly and stimulate more bone growth 
than current porous artificial bone grafts.  
 
Keywords 
bioactive glass; porous scaffolds; gel-casting; bone tissue regeneration; artificial bone graft 
  
3 
 
1. Introduction 
There is a clinical demand for artificial bone graft materials (bioactive scaffolds) that can 
stimulate bone regeneration by acting as temporary templates for vascularised bone growth. 
Applications are spinal fusions, non-union fractures of bones and other less common defects 
such as the Hills-Sacks defect in the shoulder and defects resulting from tumor removal. The 
scaffold should have an interconnected pore structure, with interconnected pore sizes that are 
greater than 100 m, be resorbable and posses the ability to stimulate bone growth (1). 
 
There are many porous bioceramic artificial bone graft products commercially available, 
usually calcium phosphates. Bioactive glass particles have been found to be more bioactive 
than synthetic hydroxyapatite in vivo (2). Bioglass
®
 45S5 (46.1% SiO2, 24.4% Na2O, 26.9% 
CaO, and 2.6% P2O5, in mol%) was the first material found to bond to bone (3) and is 
commercially available in powder form (e.g. Novabone Products LLC. Alachua, FL, USA). 
Bioactive glasses have excellent osteogenic properties due to their dissolution products 
stimulating gene up-regulation in osteoblasts (4-5). Porous amorphous glass scaffolds have 
not been made from Bioglass
® 
as it crystallizes to form a glass-ceramic when sintered (6), 
which greatly reduces its bioactivity. Glass-ceramic scaffolds based on 45S5 composition 
with an open pore structure have been produced by using sacrificial polymer foam templating, 
but compressive strength was less than 0.5 MPa, with ~85% porosity. An apatite layer was 
also not clearly formed until 4 weeks immersion in SBF (7).  During scaffold production 
from glass particles, the particles must be sintered together and Bioglass
®
 crystallises during 
this process because it has a very narrow sintering window, which is the temperature gap 
between its glass transition temperature (Tg) and its onset temperature for crystallisation (Tc 
onset). In order to sinter a glass by viscous flow sintering, the temperature must be well above 
Tg but below the Tc onset. Crystallisation reduces bioactivity of the Bioglass
®
 and as bioactive 
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glasses exhibit strongly surface nucleated crystallisation, viscous flow sintering will be 
dramatically reduced if the glass crystallises. As a result of the poor processing characteristics 
of the 45S5 glass, alternative routes were pursued for making bioactive glass scaffolds such 
as the sol-gel foaming method (8-10). However sol-gel glass may degrade too rapidly for 
certain applications where the bone will take a long time to regenerate. 
 
The first amorphous melt-derived bioactive glass scaffold produced with a pore structure 
suitable for bone ingrowth was developed by Fu et al. where the polymer foam replication 
technique was used with a glass composition 13-93 (54.6 mol% SiO2, 22.1 mol% CaO, 6.0 
mol% Na2O, 7.7 mol% MgO, 7.9 mol% K2O, 1.7 mol% P2O5). The composition expanded 
the sintering window compared to 45S5 glass and allowed the glass to be sintered without 
crystallisation. The scaffolds sintered well and established an interconnected pore network 
with pores in the range of 100-500 µm (~85% porosity) and achieved a compressive strength 
of 11 MPa, which is at the upper range of that of trabecular bone (2-12 MPa) (11). However 
the scaffolds only nucleated apatite in SBF after 7 days immersion, with the SBF being 
refreshed daily. This may be too low for a rapid bond to form in vivo. The foam replication 
process is also difficult to upscale for mass production, due to problems with removing 
excess glass slurry prior to sintering, in addition to the common problem of hollow centered 
struts that one would often find in this kind of scaffolds. The aim of this work was therefore 
to produce a porous scaffold with improved bioactivity using a processing method that can be 
up-scaled to the required ISO standards. 
 
Gel-casting is a technique that has previously been used to produce dense or porous ceramic 
or metal structures. The process involves forming a gel by in situ polymerization of organic 
monomers (12-13), in doing so the gel binds the particles and is burnt out during sintering of 
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the particles. The process was adapted by Sepulveda et al. to produce porous hydroxyapatite 
(HA) foams by introducing a foaming step into the original process prior to gelation (14-17).  
The HA foams had superior interconnected pore networks to those produced by more 
conventional methods, such as sacrificial space holder technique, and improved mechanical 
properties over those produced by sacrificial polymer foam templating.  
 
The aim of this work is to produce an amorphous melt-derived bioactive glass porous 
scaffold with a suitable pore network for bone in-growth. The glass composition was 
designed to allow sintering but also have a bioactivity similar to the 45S5 composition, by 
keeping the network connectivity (mean number of bridging oxygen bonds per silicon atom) 
as close to 2 as possible (18). Equation 1 was derived by Ray et al. (19) to calculated network 
connectivity of the glass, however a modified version that takes into account of phosphorus 
form Q
0
 orthophosphate structure was used to calculate the network connectivity in this paper, 
an example of such calculation is displayed as Equation 2 in the case of Bioglass
®
.  
 
     
                                                       
                           
 
(1) 
     
                                            
        
 
(2) 
The gel-cast foaming process was chosen because it has the potential to produce highly 
connected spherical pores and its ability of mass reproduction. The objectives were to adapt 
the gel cast foaming process for use with glasses by investigating the processing variables 
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and to produce a bioactive glass scaffold which has compressive strength similar to porous 
bone and an interconnected pore structure suitable for bone regeneration. 
2. Materials and methods 
2.1 Glass characterization  
ICIE 16 (49.46% SiO2, 36.27% CaO, 6.6% Na2O, 1.07% P2O5 and 6.6% K2O, in mol%) was 
the chosen glass composition (18). The relevant oxides were mixed together in their relative 
proportions and heated to 1420 ˚C, in a platinum crucible, and held for 1.5 h followed by 
quenching in water at room temperature. The coarse frit form of the glass was collected and 
dried overnight. The solid form of the glass was ground to a powder (Glen Creston Ltd. Gy-
Ro Mill) and sieved at < 38 µm (Endecotts EFL 2000/1). 
 
Differential Scanning Calorimetry (DSC) (Stanton Redcroft DSC 1500, Polymer Laboratories, 
Loughborough, UK) using a ramp rate of 10 ˚C /min to a final temperature of 950 ˚C, with 
matched platinum crucibles, was applied to study the differences in the glass transition 
temperatures and crystallisation behaviour of ICIE 16 and Bioglass
®
 (46.1% SiO2, 26.9% 
CaO, 24.4% Na2O, 2.6% P2O5, in mol%). The modal particle sizes (D50 value from laser 
scattering, CILAS 1064) of both glasses were 8 µm.  
 
2.2 Verification of the gel-casting foaming process variables 
Porous glass foams were produced by adapting the gel-cast foaming process, Figure 1 shows 
the steps in the process and Table 1 details the reagents and their role in the procedure, based 
on the work by Sepulveda et al. (14-17, 20).  
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Glass powder was mixed with deionised (18) water, the monomer (acrylamide) and the 
cross linker (N, N’-methylene bisacrylamide) to produce a slurry. The dispersant (Dispex) 
was added to help further dispersion of glass powder in the solution. The mixture was then 
vigorously agitated to produce a foam with the aid of the surfactant (Triton X100). 
Polymerization was activated by the addition of the initiator (ammonium persulfate solution, 
concentration 0.52 gml
-1
) and the catalyst (tetramethylethylene diamine), which reacted with 
each other releasing a free radical particle. This free radical then reacted with both the 
acrylamide and the N, N’-methylene bisacrylamide, forming a polymer network. Viscosity 
increased over a period of 1 minute until gelation. Immediately (~2 or 3 seconds) prior to the 
gelation, the foam was cast into moulds. The pore structure was stabilized by the completion 
of gelation. It was then dried and sintered to burn out the organic matter, leaving the porous 
glass network. 
 
Apart from the monomer (6 g), the crosslinker (3 g), the dispersant (2 drops) and the 
surfactant (0.1 ml), which were kept constant throughout, the influence of all other 
components on both the gelling time and the foam body was investigated systematically. 
Using a base protocol of 14 g glass, 20 ml water, 6 g monomer, 3 g crosslinker, 6 ml catalyst, 
4 ml initiator, together with 2 drops of dispersant and 0.1 ml surfactant, the effect of varying 
water content (10 ml, 12 ml, 14 ml, 16ml, 18 ml, 20 ml, 22 ml, 26 ml, 28 ml and 30 ml) and 
catalyst content (3 ml, 4 ml, 5 ml and 6 ml) were investigated. Then the effect of particle size 
was observed using the base protocol with 3 ml catalyst. Two particle size ranges were 
collected after sieving the ground frit with a 38 µm sieve: >38 µm and <38 µm. The glass 
powder loading in the slurry (10 g, 14 g and 30 g) in 20 ml water with 3 ml catalyst was then 
investigated. The effect of initiator (APS solution) freshness was also evaluated. As a result 
of this study, the base protocol was modified to: 20 g glass, 18 ml water, 6 g monomer, 3 g 
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crosslinker, 4 ml catalyst, 4 ml initiator, 2 drops of dispersant and 0.1 ml surfactant. The 
effect of initiator content (1 ml, 2 ml, 3 ml, 4 ml, 5 ml, 6 ml and 7 ml) on gelling time and 
foam body volume was then verified. 
 
2.3 Temperature Control 
The effects of drying and sintering temperature were then assessed. The gelled foams were 
dried at different temperatures: 100 ˚C, 125 ˚C and 150 ˚C, followed by a two stage sintering 
programme where the temperature was ramped to 350 ˚C at 2 ˚C/min and held for 1 h; then 
ramped again to either 680 ˚C, 700 ˚C, 710 ˚C or 730 ˚C at 2 ˚C/min and held for 1 h; 
followed by furnace cooling to room temperature. X-ray diffraction spectrometry (Philips PW 
1729 X-ray generator and PW1710 control system, operating at 40kV and 40mA) was 
performed on the samples (in powder form), and diffraction patterns were obtained in order 
to evaluate the sufficiency of sintering and the degree of crystallinity. The diffraction patterns 
were matched using the PANalytical X’Pert HighScore Plus (version 2.2b) software program. 
 
2.4 Scaffold characterisation 
The scaffolds were compared by imaging using scanning electron microscopy (SEM, JEOL 
JSM-5610) and X-ray microtomography (µCT, Phoenix X-ray Systems and Services GmbH, 
operating at 100 kV and 100 μA). A JEOL-6500F LEO FEG SEM was used to carry out 
energy-dispersive X-ray spectroscopy (EDX).  
The compressive strength of the optimum scaffold was determined using a Zwick/Roell Z2.5 
with a 2 kN load cell and a strain rate of 0.5 mm/min. Samples were cylinders, 6 mm in 
diameter 12 mm in height and the test was repeated 7 times.  
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The interconnect size was measured by mercury intrusion (Quantachrome Pore Master 33) 
and by applying a 4-step image analysis process to 3D µCT images, which had to be 
modified from previous studies to account for the complexity of the pore network (21-23): 
1. A 3×3×3 median filter was applied to remove the noise and then the image was 
binarised into two phases: the struts and the background (void spaces which were 
identified as the pores). A 5×5×5 morphological closing operator (dilation followed by 
erosion) was then applied to remove the fine intra-strut porosity, which otherwise 
reduces the watershed accuracy (step 3 below).  
 
2. A distance map was then generated by successive dilation of the strut phase until all the 
pore voxels were filled. The distance function is then the number of steps need to reach 
that voxel in the pore, while the final voxels to be filled, or regional maxima in the 
distance in the 3D distance map, were tagged as the macropore centroids (21-22).  
 
3. A 3D watershed algorithm (24) was then applied to the distance map and centroids. A 
watershed algorithm uses the rise and fall the distance map values to group voxels 
together where any water falling on those voxels would all run down to the same local 
minima. Here, the distance map is inverted and the lowest values at the struts are high 
point ridges where the water sheds into the centroid segmenting the space between 
struts into different macropores. Once the marcropores are defined, the interconnects 
are easily indentified as groups of voxels touching two macropores.  
 
4. After the pore space was segmented thoroughly, the sizes of each pore and interconnect 
could be represented by their equivalent diameters. The equivalent diameter of a pore 
was the diameter of a sphere that has the same volume to this pore. The equivalent 
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diameter of an interconnect was firstly quantified by using a principal component 
analysis (PCA) based method (23). This particular method found the best fit principal 
plane to each interconnect and projected all the voxels that belonged to that 
interconnect to the principal plane. The diameter of a circle with the same area of the 
projected voxels shade was the equivalent diameter of the interconnect.  
The scaffolds were immersed in simulated body fluid (SBF) solution (25) (75 mg of glass per 
50 ml of SBF) for up to 2 weeks in order to study dissolution rate of the glass and deposition 
rate of the hydroxycarbonate apatite (HCA) layer, which were investigated by applying 
inductively coupled plasma optical emission spectroscopy (ICP-OES, Thermo Scientific ICP 
6000 series) and Fourier transform infrared (FTIR) spectroscopy respectively (Bruker Vector 
22). Each data point was repeated at least 3 times in order to verify the error. 
 
3. Results and discussion 
Figure 2 shows the DSC traces of the 45S5 Bioglass

 and ICIE 16. By modifying the 
composition of Bioglass
 
to produce ICIE 16, the Tg increased from just over 500 ˚C to 575 
˚C and the onset temperature for crystallization (Tc onset) increased from a little over 550 ˚C to 
over 725 ˚C whereas Tc increased from 600 ˚C to over 750 ˚C. The sintering window is 
defined as Tc onset - Tg. For ICIE 16 it was greater than 200C compared to less than 100C for 
Bioglass

. The DSC data indicates that sintering the ICIE 16 glass below 750C should 
prevent crystallization.   
To create an interconnected pore network suitable for bone regeneration, it is very important 
to maintain a certain volume of foam during agitation (e.g. 130 ml from an original 
suspension of 40 ml) until polymerization occurs (e.g. 90 seconds). This is because too high a 
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foam volume would result in very large pores and low mechanical strength whereas too little 
would give insufficient pore and interconnect size. Therefore to investigate the effect of 
process variables on the pore structure, the foam body volume was used. In pilot studies, a 
foam body volume of approximately 130 m was found to produce modal interconnect 
diameters > 100m (10). The timing is critical because a rapid gelling time was not sufficient 
for the foam to develop but with too much time in agitation the foam collapsed and lost its 
stability. The glass composition and the particle size of the glass powder did not affect the 
gelling time and foam body volume. Water, catalyst and initiator content, on the other hand, 
played a significant role. 
 
The amount of water in the system had a large impact on the gelling time and foam body. 
Figure 3a shows that as the water content increased from 10 to 30 ml, the average gelling 
time also increased from 50 to 114 seconds (127% increase), and the foam body increased 
from 50 to 192 ml (283% increase) respectively. The increase in gelling time was due to 
dilution of the reagents, but the increase in foam volume was due to the water increasing the 
efficiency of the surfactant. 
 
The effect of catalyst concentration was different (Figure 3b). As catalyst content increased 
from 3 to 4 ml, there was a sharp decline in the gelling time from 126 to 96 s. The gelation 
time was approximately constant (83 s) as the catalyst content increased from 5 to 6 ml. The 
foam volume reduced gradually from 170 to 167 ml as the catalyst content increased from 3 
to 4 ml and decreased sharply (from 158 to 110 ml) as the catalyst volume increased from 5 
to 6 ml, even though the gelling time was approximately the same at these two data points. 
The ideal foam body was around 130 ml and an ideal gelling time for producing a stable 
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foam body was around 90 s, so 18-22 ml of water was suitable for the process. 18 ml of water 
and 4 ml of catalyst were chosen to be the standard quantities. 
 
As the initiator content increased from 1 to 7 ml, the gelling time decreased (182 to 51 s) and 
the foam body volume increased from 130 to 170 ml (Figure 3c). The relationship was not 
linear over the range of concentrations used: as initiator content increased from 1 to 3 ml 
there was a sharp decline in gelling time from 182 to 84 s whilst the foam volume changed 
little, reducing from 130 to 124 ml. Then, as initiator content increased from 3 to 7 ml the 
gelation time decreased more slowly from 84 to 51 s and the relationship was approximately 
linear. The foam volume increased approximately linearly from 124 ml to 170 ml. Changing 
the initiator content changed the water content of the solution. The total change in water 
content through the range of initiator contents used was ± 3 ml. Figure 3a shows that ± 3ml 
had little effect on foam volume or gelling time, therefore the differences observed in Figure 
3c can be attributed to the initiator rather than to changes in water content. 
 
In addition to the above components, the vitality of the initiator (APS) solution influenced the 
gelling time and the foam body volume of the suspension significantly. After mixing the APS 
powder with distilled water, it had to be left for at least 3 h before it could be used, otherwise 
the suspension would not foam at all, even though the gelling time was not affected. The 
solution became less reactive as time passed; therefore it was remade after 1 week. If the 
solution was left more than 1 week the gelling time was significantly prolonged. 
 
The influence of the size of the glass particles played a critical role in sintering. Particle size 
measurements showed that for particles sieved to <38 µm, their size distribution ranged from 
1.31 µm (D10 value) to 37.73 µm (D90 value) with a mode (D50) value of 8.65 µm. The >38 
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µm particles had a particle size range of 75 µm to 89.70 µm with a modal value of 84.15 µm. 
When >38 µm particles were used, sintering was not completed at 700 ˚C (Figure 4a). The 
foam struts were not fully dense and consisted of large particles embedded in a sea of smaller 
particles, which were loosely attached to one another, and the scaffold structure was fragile. 
The pore network collapsed during sintering. When <38 µm particles were used, the structure 
was intact and the scaffold was well sintered (Figure 4b). Particle packing and stacking 
during sintering was better for the <38 µm particles. The smaller particles have a greater 
driving force for sintering and must be used in order to allow efficient sintering at 700 ˚C. 
However, smaller particles have a larger surface area for crystal nucleation and are also likely 
to promote crystallization at lower temperatures (see later). 
 
A side effect of using APS as the initiator was that crystallites were present in the glass after 
sintering (Figure 5a). These were not due to crystallization of the glass, but were identified by 
XRD (Figure 6) to be potassium sodium sulfate (K3Na(SO4)2) (01-074-0398). Due to the 
glass being in contact with water during the process, sodium and potassium ions were 
dissolved from the glass in an ion exchange mechanism. The ions reacted with the sulfate, 
which was a by-product of the initiator (APS), causing nucleation of crystals on the surface of 
the glass particles. As the scaffold was sintered, the organic part was burnt out, leaving glass 
particles stacked in a porous glass structure, which then fused together as the temperature 
increased further. The crystals were therefore incorporated into the glass. Although the 
gelling time was short (90 s), the glass remained in contact with water during drying. Small 
amounts of K3Na(SO4)2 may not affect biological properties (26-27) and materials such as 
calcium sulphates have been clinically used as synthetic bone graft material for over a 
century without failing (28), but methods to eliminate its formation were devised regardless. 
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Attempts were made to eliminate the K3Na(SO4)2 formation by reducing the amount of water 
present and the amount of time the water is in contact with the glass, by increasing the drying 
temperature. Figure 5 shows SEM micrographs of the glass surface for scaffolds sintered at 
700 ºC but dried at 100 ˚C, 125 ˚C and 150 ˚C. The size of the crystals was significantly 
reduced from ~70 µm when dried at 100 ˚C (Figure 5a) to ~20 µm by drying at 150 ˚C 
(Figure 5c). However, drying at 150 ˚C caused the glass to crystallize, which could be seen in 
Figure 6c and therefore the optimum drying temperature was considered to be 125 ˚C.  
 
Figure 6 shows XRD traces for the glass scaffolds for each sintering temperature following 
drying at 100 ˚C (Figure 6a), 125 ˚C (Figure 6b) and 150 ˚C (Figure 6c). Drying at 125 ˚C 
(Figure 6b) suppressed the K3Na(SO4)2 formation to a minimum without the glass 
crystallizing too much. As the sintering temperature increased above 700 ˚C, scaffolds dried 
at all temperatures began to crystallise, the crystal phases were a mixture of potassium 
sodium sulfate (K3Na(SO4)2) and sodium calcium silicate (Na2CaSi3O8) (01-077-2189). This 
means that the gel-casting process combined with the slower heating rate had reduced the Tc 
onset of the glass to a lower temperature (<700 ˚C) compared to the Tc onset that was derived 
from the DSC trace in Figure 2 (725 ˚C).  
 
Comparing Figure 6a and Figure 6b, there was less crystallisation of the glass in the scaffolds 
dried at 100 ˚C (Figure 6a), The degree of crystallinity increased as the drying temperature 
increased to 125 ˚C (Figure 6b), which means the crystallisation temperature of the glass was 
reduced and drying at higher temperature promoted the onset of glass crystallisation. 
 
The higher drying temperatures may have also lowered the onset crystallization temperature 
of the glass by increasing the ion diffusion rate and therefore a low sintering temperature 
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would minimise crystallisation of the glass and growth of the K3Na(SO4)2 crystals, but 
sintering was not efficient at temperatures below 680 ˚C and therefore the desired sintering 
temperature was between 680 ˚C and 700 ˚C. 
 
Another option was to reduce the amount of initiator used in the process. Figure 7 shows that 
as the initiator volume decreased from 4 to 1 ml, the crystallization of the K3Na(SO4)2 were 
suppressed as there was less sulfate available. No crystallites were observed on scaffolds 
made with 1 ml APS (Figure 7a). However 1 ml of the initiator could not efficiently gel the 
system, therefore 2 ml was the optimum amount of initiator to be applied in the gel-casting 
process. 
 
In summary, small particle size promoted sintering at lower temperature but also promoted 
glass crystallization. As initiator content increased, gelling time decreased and pore size 
increased. However, more importantly, too much initiator (ammonium persulfate) resulted in 
the formation of potassium sodium sulfate crystals in the scaffold, due to the sulfate left from 
the initiator reacting with glass dissolution products in the aqueous slurry. The drying 
temperature was increased to reduce the amount of water and time that the glass was exposed 
to water; however this stimulated crystallization of the glass when it was raised too much. An 
optimal drying temperature was therefore chosen and the amount of initiator was therefore 
reduced to a minimum. Sintering temperature was also critical, as temperatures above 700 ˚C 
triggered crystallization and temperatures below 680 ˚C did not allow complete sintering of 
the particles.  
 
An optimal protocol for the gel-cast foaming of ICIE 16 was therefore devised. The size of 
the glass powder should be around 10 µm, and the standard formula of the process was: 20 g 
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glass powder, 18 ml water, 6 g methacrylamide (monomer), 3 g N,N’-methylene 
bisacrylamide (cross-linker), 2 ml ammonium persulfate solution (initiator), 0.1 ml Triton X 
(surfactant), 4 ml tetramethylethylene diamine (TEMED) (catalyst). The foams were dried at 
125 ˚C for 10 h, and then ramped at 2 ˚C/min to 350 ˚C, held for 1 h and was ramped up 
again at 2 ˚C/min to 700 ˚C, held for 1 h before furnace cooling. 
 
The optimised scaffolds were characterized to determine whether the interconnect size was 
sufficient for blood vessel penetration and tissue ingrowth, i.e. greater than 100 µm. Figure 
8a shows the data obtained by mercury intrusion porosimetry, from which the modal sizes of 
the interconnect were determined to be 128 µm (80% porosity). Figure 8b is a 3D µCT image 
of the structure of a representative optimized scaffold and is the visual evidence of the high 
interconnectivity and porosity of the scaffold. Three such scaffolds were scanned and the 
interconnect size distributions from CT image analysis are shown in Figure 8c. ICIE16 1 is 
the sample imaged in Figure 8b. The mean modal interconnect size of the three samples was 
140 µm. The image analysis of µCT images also allowed quantification of pore size (Figure 
8d), which had a mean modal pore size of 379 µm.  
 
Nine preliminary compression tests were carried out to investigate the compressive strength 
of the scaffolds and the results were summarized in Table 2. The individual values are shown 
in Table 2 since there was a small variation in porosity between samples. For a scaffold with 
79% porosity, modal pore size of ~345 µm and modal interconnect size of 144 µm, its 
compressive strength was 1.9 MPa. Overall the compressive strength increased as the 
porosity decreased.  
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The scaffold with a bulk density of 0.52 gcm
-3
 and a porosity of 81% was immersed in SBF 
for the purpose of deposition and dissolution rate studies. The deposition of HCA was 
inspected by FTIR and the results were summarized in Figure 9a. It is clear that the 
deposition of calcium phosphate occurred after 8 h of immersion in SBF, as P-O bend bands 
were seen for the first time, which is likely to be amorphous calcium phosphate. Amorphous 
calcium phosphate deposition has previously been found to occur on bioactive glasses, prior 
to HCA formation, using synchrotron X-ray diffraction studies (29-30). The twin P-O 
bending bands at 576 and 611 cm
-1
 indicate the calcium phosphate crystallized into HCA 
after 3 days immersion. The fact that the P-O bending peaks corresponded to HCA was 
confirmed by XRD (Figure 9b). Apatite formation in SBF was therefore at a similar rate to 
sol-gel foam scaffolds that had a similar compressive strength (31) and more rapid than the 
13-93 scaffolds. The reason of the more rapid HCA layer formation on the ICIE16 scaffolds 
is that the network connectivity of ICIE16 is 2.13, which is very close to that of Bioglass
®
 
(2.11); whereas the network connectivity of 13-93 is a lot higher, at 2.59, as the result of the 
higher silica content of 13-93. A higher network connectivity means that the glass is less 
susceptible to ion exchange and dissolution, which are the first stages of the HCA layer 
formation mechanism, therefore apatite nucleation is slower on 13-93. 
 
Figure 10 shows the dissolution (ICP) data where Si, Ca, S, K and Na were all released 
slowly into the SBF. The phosphorus was taken up by the sample from the solution and none 
was left after 1 week of immersion, indicating P deposition on the glass. After 1 day in SBF, 
there was an increase of phosphorus in the solution but a decrease in all other elements except 
calcium. It is therefore possible that some amorphous calcium phosphate deposited on the 
glass and then redissolved before reprecipitating on the glass again. This has been observed 
in sol-gel derived bioactive glasses using synchrotron XRD (32-33). Approximately 35 ppm 
18 
 
of sulfur was released into the solution after 2 weeks, which was from the potassium sodium 
sulfate crystallites. Sulfur is non-toxic in its element form and is a vital component of all 
living cells, at a quantity this small it is unlikely to provoke any response from the body. 
 
Conclusion 
Bioactive glass foam scaffolds were produced of the ICIE 16 composition (49.46% SiO2, 
36.27% CaO, 6.6% Na2O, 1.07% P2O5 and 6.6% K2O, in mol%) by adapting the gel-casting 
foaming process. Open porous structures were achieved with interconnects exceeding 100 μm 
in diameter while maintaining the amorphous structure of the glass. The optimum scaffold 
was produced by applying the standard protocol that consists of 20 g glass powder, 18 ml 
water, 6 g monomer (acrylamide), 3 g crosslinker (N, N’-methylene bisacrylamide), 4 ml 
catalyst (TEMED), 2 ml initiator (APS Solution), 2 drops of dispersant and 0.1 ml surfactant 
(Triton X). All the parameters listed above influenced the gelling time and the porosity. The 
size of the glass powder is critical for sintering efficiency. Particles with a particle size range 
of 1 - 10 µm sintered well, while larger particles did not. The initiator concentration, the 
water concentration and the drying and sintering temperatures affected the amount of 
potassium sodium sulfate formation that occurred during processing. A decrease in any of 
these parameters resulted in less crystallization. 2 ml of initiator solution and 18 ml water, 
together with a drying temperature between 125 ˚C and 150 ˚C and a sintering temperature 
between 680 ˚C and 700 ˚C produced the optimum scaffold. Optimized scaffolds had modal 
interconnect sizes of 141 µm  and  modal pore size was 379 µm. The scaffolds also had a 
compressive strength at the lower end of that of trabecular bone (1.9 MPa). Calcium 
phosphate deposited on the scaffolds after 8 h of immersion in SBF and crystallized into 
HCA after 3 days immersion.  
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Figure Captions 
 
Figure 1. Flow chart of the gel-cast foaming process. 
 
Figure 2. DSC traces of 45S5 Bioglass
®
 and ICIE16 (particles <38m) with a heating rate of 
10ºC. 
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Figure 3. Gelling time and foam body volume of the gel cast foam as a function a) water 
content, b) catalyst content and c) initiator content. 
  
23 
 
 
Figure 4. SEM images of glass scaffolds produced with particles with size distributions of 
a) >38 µm and b) <38 µm particles. Both were dried at 100 ˚C and sintered at 700 ˚C.  
 
Figure 5. SEM images of scaffolds dried at a) 100
 ˚C, b) 125 ˚C and c) 150 ˚C, which were 
then sintered to 350
 ˚C followed by 700 ˚C.  
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Figure 6. XRD traces of scaffolds dried at a) 100 ˚C, b) 125 ˚C and c) 150 ˚C, sintered at 
different temperatures. Peaks marked with * represent the crystallization of potassium sodium 
sulfate, and the peaks with × mark the crystallization of the glass.  
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Figure 7. SEM images of bioactive glass foam scaffolds gel cast with initiator volumes of a) 
1ml, b) 2ml, c) 3ml, and d) 4ml.  
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Figure 8. Pore network quantification: a) mercury porosimetry and b) a X-ray 
microtomography (µCT) image of a gel cast foam scaffold, c) interconnect diameter 
distribution from image analysis of µCT images, d) pore size distributions from image 
analysis of µCT images. 
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Figure 9. a) FTIR traces of the scaffolds immersed in SBF up to 2 weeks, and b) XRD traces 
of the ICIE16 glass powder (<38 µm) before processing and after immersion of the scaffold 
in SBF for 2 weeks. 
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Figure 10. Concentrations of the different ions released from the scaffolds after immersion in 
SBF for up to 2 weeks (ICP data) 
 
(a) (b)
